Venlafaxine Hydrochloride
"Venlafaxine Hydrochloride" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A cyclohexanol and phenylethylamine derivative that functions as a SEROTONIN AND NORADRENALINE REUPTAKE INHIBITOR (SNRI) and is used as an ANTIDEPRESSIVE AGENT.
| Descriptor ID |
D000069470
|
| MeSH Number(s) |
D02.033.415.510.500.901 D02.092.471.683.948 D02.455.426.392.368.367.318.750 D10.289.510.500.901
|
| Concept/Terms |
Venlafaxine Hydrochloride- Venlafaxine Hydrochloride
- Hydrochloride, Venlafaxine
- Cyclohexanol, 1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)-, hydrochloride
- 1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)cyclohexanol HCl
Wy 45030- Wy 45030
- Wy-45030
- Wy45030
- Wy-45,030
- Wy 45,030
- Wy45,030
Effexor- Effexor
- Trevilor
- Vandral
- Efexor
|
Below are MeSH descriptors whose meaning is more general than "Venlafaxine Hydrochloride".
Below are MeSH descriptors whose meaning is more specific than "Venlafaxine Hydrochloride".
This graph shows the total number of publications written about "Venlafaxine Hydrochloride" by people in this website by year, and whether "Venlafaxine Hydrochloride" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 2 | 2 |
| 2012 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 6 | 1 | 7 |
| 2018 | 3 | 1 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Venlafaxine Hydrochloride" by people in Profiles.
-
Discontinuation Syndrome of Extended-Release Venlafaxine during the COVID-19 Epidemic. Psychiatr Danub. 2021; 33(1):121-122.
-
Sex and body weight are major determinants of venlafaxine pharmacokinetics. Int Clin Psychopharmacol. 2018 11; 33(6):322-329.
-
Bilateral sciatic neuropathy with severe rhabdomyolysis following venlafaxine overdose: A case report. Medicine (Baltimore). 2018 Sep; 97(37):e12220.
-
Executive Function Predicts Antidepressant Treatment Noncompletion in Late-Life Depression. J Clin Psychiatry. 2018 May/Jun; 79(3).
-
Effect of Problem-Solving Therapy Versus Supportive Management in Older Adults with Low Back Pain and Depression While on Antidepressant Pharmacotherapy. Am J Geriatr Psychiatry. 2018 07; 26(7):765-777.
-
Effect of Metabolic Syndrome on Late-Life Depression: Associations with Disease Severity and Treatment Resistance. J Am Geriatr Soc. 2017 Dec; 65(12):2651-2658.
-
Exploring venlafaxine pharmacokinetic variability with a phenotyping approach, a multicentric french-swiss study (MARVEL study). BMC Pharmacol Toxicol. 2017 11 07; 18(1):70.
-
Short-term efficacy and tolerability of venlafaxine extended release in adults with generalized anxiety disorder without depression: A meta-analysis. PLoS One. 2017; 12(10):e0185865.
-
Therapeutic Drug Monitoring of Venlafaxine in an Everyday Clinical Setting: Analysis of Age, Sex and Dose Concentration Relationships. Basic Clin Pharmacol Toxicol. 2017 Oct; 121(4):298-302.
-
Bone Turnover with Venlafaxine Treatment in Older Adults with Depression. J Am Geriatr Soc. 2017 Sep; 65(9):2057-2063.